![Clinical [89Zr]Dinutuximab PET imaging to determine GD2 expression in neuroblastoma patients with PET](https://images.squarespace-cdn.com/content/v1/60b687d7c75a235d721c70d5/8c900f9c-6d15-45da-8393-2b43144a123d/Princess+Maxima.png)
Clinical [89Zr]Dinutuximab PET imaging to determine GD2 expression in neuroblastoma patients with PET
Clinical [89Zr]Dinutuximab PET imaging to determine GD2 expression in neuroblastoma patients with PET
Dr. Max M. van Noesel, MD. PhD, MSc; – Princess Máxima Center, Utrecht, The Netherlands
Development of a novel radiopharmaceutical agent for non-invasive immunotherapy target detection and CAR T combination therapy in neuroblastoma
Development of a novel radiopharmaceutical agent for non-invasive immunotherapy target detection and CAR T combination therapy in neuroblastoma
Dr. Rosa Nguyen, M.D., Ph.D. – National Cancer Institute, NIH NCI Pediatric Oncology, Bethesda, MD
Targeted Nanoparticles for Genetic Engineering of Human Natural Killer Cells for Neuroblastoma Therapy
Targeted Nanoparticles for Genetic Engineering of Human Natural Killer Cells for Neuroblastoma Therapy
Dr. Ketan Ghaghada, Ph.D. – Baylor College of Medicine, Houston TX
Epitranscriptomic mechanisms of therapy resistance in high-risk neuroblastoma
Epitranscriptomic mechanisms of therapy resistance in high-risk neuroblastoma
Dr. Liron Grossmann, M.D. – The Sheba Fund for Health Service and Research, Israel
MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition
MYCN-amplified neuroblastoma are addicted to iron and vulnerable to system Xc- inhibition
Virginia Commonwealth University, Richmond, VA
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
Arginine methylation as a potential therapeutic target in high-risk neuroblastoma
University of Rochester, Rochester, NY
Activation of NF-kB in Neuroblastoma Myeloid Cells
Activation of NF-kB in Neuroblastoma Myeloid Cells
Johns Hopkins University School of Medicine, Baltimore, MD
Uncovering the Contribution of RNA Binding Proteins to Neuroblastoma Aggression
Uncovering the Contribution of RNA Binding Proteins to Neuroblastoma Aggression
Emory University – Winship Cancer Institute, Atlanta, GA
Disrupting Neuroblastoma Tumor-Initiating Cells
Disrupting Neuroblastoma Tumor-Initiating Cells
University of Rochester, Rochester, NY